International Journal of Pharmaceutical Compounding

A subscription to IJPC provides on-line access to full-text, full-color, printable PDF copies of your subscribed issues, individual articles, and purchased archives.

LEARN MORE

Report: USP Expert Advisory Panel on Pharmacy Compounding Practices

Author(s): Allen Loyd V Jr

Issue: Mar/Apr 1999 - Compounding for Men's Health
View All Articles in Issue

Page(s): 126-127

Report: USP Expert Advisory Panel on Pharmacy Compounding Practices Page 1

Report: USP Expert Advisory Panel on Pharmacy Compounding Practices Page 2

Download in electronic PDF format for $75

Abstract: The work of the United States Pharmacopeial Convention Expert Advisory Panel on Pharmacy Compounding Practices has far-reaching consequences for the practice of pharmacy in the development of standards for compounded medications and the manner of their preparation. This article discusses the panel and the monograph development process and summarizes activities to date.

Related Keywords: product monographs, quality control, sterility requirements, stability, pharmacy practice, Food and Drug Administration (FDA), Pharmacopeial Forum

Related Categories: BUSINESS, LEGAL, UNITED STATES PHARMACOPEIA CONVENTIONS

Printer-Friendly Version

Title/Author (Click for Abstract / Details / Purchase)	Issue/Page View/Buy
Related Articles from IJPC
Report: USP Expert Advisory Panel on Pharmacy Compounding Practices Allen Loyd V Jr	Mar/Apr 1999 Pg. 126-127
Discrepancies in the Law and the U.S. Food and Drug Administration Pharmacy Compounding Compliance Policy Guidelines Allen Loyd V Jr	Jul/Aug 2016 Pg. 351 View Sample
Applying Quality of Design Concepts to Pharmacy Compounding Timko Robert J	Nov/Dec 2015 Pg. 453-463
U.S. Food and Drug Administration Inspections: Guide to a Successful Outcome for 503A Sterile Compounding Pharmacies Yoch Doug	Mar/Apr 2017 Pg. 95-102
PreScription: 2017 Pharmacy Compounding Issues: The U.S. Food and Drug Administration, Harzardous Drugs, and Wasted Drugs Allen Loyd V Jr	Sep/Oct 2017 Pg. 356
Certification, Accreditation, and Credentialing for 503A Compounding Pharmacies Pritchett Jon, McCrory Gary, Kraemer Cheri, Jensen Brenda, Allen Loyd V Jr	Jan/Feb 2018 Pg. 7-16
Quality Assurance and Quality Control: Being Prepared for U.S. Food and Drug Administration Inspections and Staying in Compliance with United States Pharmacopeia Chapter <797>: Part 1 Martin Matt	Sep/Oct 2018 Pg. 401-404
Nominations of Difficult to Compound Drugs to the U.S. Food and Drug Administration--Pharmacy Compounding Advisory Committee: Part 1 Allen Loyd V Jr	Sep/Oct 2015 Pg. 389-390
Quality Control: Rapid Sterility Testing for Compounding Pharmacies Taylor Andrew	Jul/Aug 2020 Pg. 299-303
Quality Control Analytical Methods: A Summarized Discussion of Current Good Manufacturing Practice Regulations Allen Loyd V Jr	May/Jun 2013 Pg. 210-219
A Primer on USP Chapter 797, "Pharmaceutical Compounding - Sterile Preparations," and USP Process for Drug and Practice Standards Newton David W, Trissel Lawrence A	Jul/Aug 2004 Pg. 251-263
PreScription: State or Federal Control of Pharmacy Practice Allen Loyd V Jr	May/Jun 2007 Pg. 178
Documentation: Records and Reports Akers Michael J	Sep/Oct 2017 Pg. 373-380
Final Guidance for Pharmacy Compounding of Human Drug Products Under Section 503A Blankenship Cynthia E	Sep/Oct 2014 Pg. 379-380
U.S. Food and Drug Administration "Evaluation Criteria" for Difficult to Compound Drugs Allen Loyd V Jr	Nov/Dec 2015 Pg. 487-488
FDA-funded Report on Compounded Hormones is Tainted, Analysis Shows Brunner Scott	May/Jun 2021 Pg. 206-209
U.S. Food and Drug Administration Proposed Guidance Document: Compounding Animal Drugs from Bulk Substances Miller David G	Jul/Aug 2015 Pg. 303-305
PreScription: Compounding Pharmacy Issues for 2017 Allen Loyd V Jr	Jan/Feb 2017 Pg. 4
Quality Control: Personal Protective Equipment for Use When Handling Hazardous Drugs Dillon L R	Jan/Feb 2020 Pg. 30-36
Establishing and Standardizing Preferred Pharmacy Practices in a Multioffice Infusion Company, Part 1 Chamallas Stanley N, Sullivan Kathleen	Nov/Dec 2002 Pg. 428-432
Return to Top